| Sign In to gain access to subscriptions and/or personal tools. |
Amino Acid Solutions for Premature Neonates During the First Week of Life: The Role of N-Acetyl-L-Cysteine and N-Acetyl-L-TyrosineDepartment of Pediatrics, Division of Neonatology, Erasmus University and University Hospital Rotterdam/Sophia Children's Hospital Rotterdam, The Netherlands
Department of Pediatrics, Division of Neonatology, Erasmus University and University Hospital Rotterdam/Sophia Children's Hospital Rotterdam, The Netherlands
Department of Pediatrics, Division of Neonatology, Erasmus University and University Hospital Rotterdam/Sophia Children's Hospital Rotterdam, The Netherlands
Metabolic Laboratory, Erasmus University and University Hospital Rotterdam/Sophia Children's Hospital Rotterdam, The Netherlands
Department of Analytical Chemistry, Kabi Pharmacia, Erlangen, Germany
Department of Pediatrics, Division of Neonatology, Erasmus University and University Hospital Rotterdam/Sophia Children's Hospital Rotterdam, The Netherlands
Department of Pediatrics, Division of Neonatology, Erasmus University and University Hospital Rotterdam/Sophia Children's Hospital Rotterdam, The Netherlands Tyrosine and cyst(e)ine are amino acids that are thought to be essential for preterm neonates. These amino acids have low stability (cyst(e)ine) or low solubility (tyrosine) and are therefore usually present only in small amounts in amino acid solutions. Acetylation improves the stability and solubility of amino acids, facilitating a higher concentration in the solution. We compared three commercially available amino acid solutions, Aminovenös-N-päd 10%, Vaminolact 6.5%, and Primène 10%, administered to 20 low-birth-weight neonates on total parenteral nutrition from postnatal day 2 onward. Aminovenös-N-päd 10% contains acetylated tyrosine and acetylated cysteine; the other solutions do not contain acetylated amino acids and differ in the amount of tyrosine and cysteine added. On postnatal day 7, plasma amino acids were measured together with urinary excretion of amino acids and the total nitrogen excretion; 38% of the intake of N-acetyl-L-tyrosine and 53% of the intake of N-acetyl-L-cysteine were excreted in urine. Plasma levels of N-acetyl-L-tyrosine (331 ± 74 µmol/L) and N-acetyl-L-cysteine (18 ± 29 µmol/L) were higher than those of tyrosine (105 ± 108 µmol/L) and cystine (11 ± 9 µmol/L), respectively. Plasma tyrosine levels in the groups receiving small amounts of tyrosine remained just below the reference range. We showed a linear correlation of plasma cystine with the intake of cysteine (r = .75, p = 0.01), but not with N-acetyl-L-cysteine. The estimated intake of cysteine should be 500 µmol·kg-1·d -1 in order to obtain levels comparable with those shown in normal term, breast-fed neonates. Nitrogen retention did not differ among the three groups (247 to 273 mg·kg-1·d-1). We conclude that a large portion of parenterally administered acetylated amino acids is excreted in the urine of 1-week-old, preterm neonates, with higher plasma levels of the acetylated amino acids than of the deacetylated amino acids. (Journal of Parenteral and Enteral Nutrition 18:404-408, 1994)
Journal of Parenteral and Enteral Nutrition, Vol. 18, No. 5,
404-408 (1994) This article has been cited by other articles:
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
 |
|
Sign In to gain access to subscriptions and/or personal tools.
